Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer

NCT00911092 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

PROCEDURE: Blood sampling
RADIATION: Radiation
DRUG: Chemotherapy (Fluorouracil and Cisplatin)

Sponsor

Centre Oscar Lambret